Mechanisms and biomarkers of immune-related adverse events in gastric cancer.

Ding, Ping'an; Liu, Pengpeng; Meng, Lingjiao; Zhao, Qun

Ding, Ping'an; Liu, Pengpeng; Meng, Lingjiao; Zhao, Qun.

Afiliação

Ding P; The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China.
Liu P; Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, 050011, China.
Meng L; The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China.
Zhao Q; Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, 050011, China.

Eur J Med Res ; 28(1): 492, 2023 Nov 08.

Article em En | MEDLINE | ID: mdl-37936161

Assuntos

Antineoplásicos Imunológicos; Neoplasias Gástricas; Humanos; Antineoplásicos Imunológicos/efeitos adversos; Anticorpos Monoclonais/efeitos adversos; Citocinas; Autoanticorpos

Palavras-chave

Biomarkers; Gastric cancer; Immune-checkpoint inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Antineoplásicos Imunológicos Limite: Humans Idioma: En Revista: Eur J Med Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google